Antiangiogenic Synergism of Integrin-Targeted Fumagillin Nanoparticles and Atorvastatin in Atherosclerosis

OBJECTIVE: Studies were performed to develop a prolonged antiangiogenesis therapy regimen based on theranostic α(ν)β(3)–targeted nanoparticles. BACKGROUND: Antiangiogenesis therapy may normalize atherosclerotic plaque vasculature and promote plaque stabilization.α(ν)β(3)–targeted paramagnetic nanopa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Winter, Patrick M., Caruthers, Shelton D., Zhang, Huiying, Williams, Todd A., Wickline, Samuel A., Lanza, Gregory M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2636718/
https://ncbi.nlm.nih.gov/pubmed/19356492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmg.2008.06.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak